Biological Age as Policy Metric

Treat biological age (measured by validated molecular clocks) as an auditable public‑health metric alongside chronological age for clinical screening, prevention programs, and allocation of prevention resources. Rather than a vanity test, a standardized biomarker could guide targeted interventions to slow physiological aging, evaluate therapies, and inform insurance/regulatory decisions. — If governments and health systems adopt biological‑age metrics, it would reorient prevention, funding and regulation toward slowing aging as a disease modifier—affecting Medicare/Medicaid planning, anti‑aging research priorities, workforce health programs, and consumer protection for commercial 'age' tests.